Close
Back to MNKD Stock Lookup
Pages: 1 2 »» Last Page

MannKind (MNKD) – Major News

Feb 27, 2024 04:04 PM MannKind (MNKD) Tops Q4 EPS by 2c
Nov 7, 2023 04:02 PM MannKind (MNKD) Tops Q3 EPS by 4c
Aug 7, 2023 04:05 PM MannKind (MNKD) Tops Q2 EPS by 4c
May 9, 2023 04:05 PM MannKind (MNKD) Tops Q1 EPS by 1c
Feb 23, 2023 04:49 PM MannKind (MNKD) Misses Q4 EPS by 2c
May 7, 2019 08:10 AM MannKind (MNKD) Reports In-Line Q1 EPS
Feb 26, 2019 08:08 AM MannKind (MNKD) Q4 Revenues Rise 254%; Achieves First Ever Qtr Afrezza Gross Profit
May 9, 2018 04:29 PM MannKind (MNKD) Reports Q1 Loss of $0.25/Share
Mar 12, 2018 08:10 AM MannKind (MNKD) Restructures, Reduces Debt by $14.5M
Feb 27, 2018 04:03 PM MannKind (MNKD) Tops Q4 EPS by 1c, Revs Beat
Nov 7, 2017 04:05 PM MannKind (MNKD) Misses Q3 EPS by 11c
Aug 7, 2017 04:14 PM MannKind (MNKD) Misses Q2 EPS
May 10, 2017 04:07 PM MannKind (MNKD) Misses Q1 EPS by 8c
Mar 16, 2017 04:22 PM MannKind (MNKD) Tops Q4 EPS by 73c
Nov 9, 2016 08:32 AM MannKind (MNKD) Posts Q3 EPS of 26c, Topping Views
Aug 8, 2016 04:01 PM MannKind (MNKD) Misses Q2 EPS by 1c
May 9, 2016 04:01 PM MannKind (MNKD) Misses Q1 EPS by 2c
Mar 14, 2016 04:50 PM MannKind (MNKD) Posts Q4 Loss of 66c/Share
Jan 26, 2016 02:33 PM MannKind (MNKD) Said Exploring Possible Sale
Jan 21, 2016 09:01 AM MannKind (MNKD) Enters Into Collaboration and License Agreement with Receptor Life Sciences
Jan 11, 2016 09:06 AM MannKind (MNKD) Says DeSisto Won't Be President & CEO; Names Matthew Pfeffer as CEO
Jan 11, 2016 09:03 AM MannKind (MNKD) Withdraws CEO Offer to Duane DeSisto; Matthew Pfeffer to Assume Role
Jan 5, 2016 09:03 AM MannKind (MNKD) Announces Termination of Licensing Agreement with Sanofi (SNY); Will Evaluate Options for Afrezza
Jan 5, 2016 09:02 AM MannKind (MNKD) Announces Termination of Its License Agreement With Sanofi (SNY)
Dec 23, 2015 05:31 PM MannKind (MNKD) Names Duane DeSisto as President and CEO
Nov 20, 2015 08:01 AM MannKind (MNKD) CEO Edstrom Steps Down
Nov 9, 2015 10:18 AM MannKind (MNKD) Misses Q3 EPS by 1c
Aug 10, 2015 08:01 AM MannKind (MNKD) Tops Q2 EPS by 1c
May 8, 2015 07:50 AM MannKind (MNKD) Reports In-Line Q1 Loss of 8c/Share
Jan 12, 2015 07:06 AM MannKind (MNKD) CEO Alfred Mann to Retire; Will Transition to Executive Chairman
Nov 3, 2014 09:02 AM MannKind (MNKD) Posts Q3 Loss of 9c/Share
Aug 11, 2014 09:02 AM Mannkind Corp (MNKD) Posts Q2 Loss of 19c/Share
Aug 11, 2014 05:51 AM MannKind (MNKD) Inks Afrezza Licensing Agreement with Sanofi (SNY)
Jun 27, 2014 03:28 PM MannKind (MNKD) Wins FDA Approval for Afrezza Inhaled Insulin; Will Require Post-Marketing Studies
May 12, 2014 09:02 AM Mannkind Corp (MNKD) Posts Q1 Loss of 14c/Share
Apr 1, 2014 05:50 PM MannKind (MNKD): FDA Advisory Committee Recommends Approval of AFREZZA(R)
Apr 1, 2014 05:50 PM Mannkind (MNKD) Confirms FDA Panel Backs AFREZZA for Diabetes
Feb 18, 2014 08:06 AM Mannkind Corp (MNKD) Posts Q4 Loss of 16c/Share
Nov 4, 2013 09:02 AM Mannkind Corp (MNKD) Posts Q3 Loss of 17c/Share
Aug 9, 2013 04:00 PM Mannkind Corp (MNKD) Misses Q2 EPS by 2c
May 9, 2013 04:04 PM Mannkind Corp (MNKD) Reports In-Line Q1 EPS
Feb 11, 2013 04:01 PM Mannkind Corp (MNKD) Posts Q4 Loss of 23c/Share
Nov 1, 2012 04:27 PM Mannkind Corp (MNKD) Tops Q3 EPS by 2c
Aug 7, 2012 08:03 AM Mannkind Corp (MNKD) Posts Q2 Loss of 23c/Share
May 9, 2012 04:04 PM Mannkind Corp (MNKD) Posts Q1 Loss of 27c/Share
Feb 22, 2012 04:00 PM Mannkind Corporation (MNKD) Tops Q4 EPS by 2c
Nov 3, 2011 05:50 PM Mannkind Corporation (MNKD) Posts Q3 Loss of $0.31
Aug 4, 2011 04:14 PM Mannkind Corp. (MNKD) Posts Wider than Expected Q2 Loss
May 9, 2011 04:01 PM Mannkind Corporation (MNKD) Posts Q1 Loss of $0.34, Misses Views
Feb 10, 2011 04:02 PM MannKind Corp. (MNKD) Posts Narrower than Expected Q4 Loss
Pages: 1 2 »» Last Page

Back to MNKD Stock Lookup